DANESE, Silvio
 Distribuzione geografica
Continente #
NA - Nord America 136
EU - Europa 133
AS - Asia 46
AF - Africa 6
OC - Oceania 4
SA - Sud America 2
Totale 327
Nazione #
US - Stati Uniti d'America 130
IT - Italia 72
GB - Regno Unito 19
IN - India 13
JP - Giappone 11
CZ - Repubblica Ceca 7
NL - Olanda 6
HK - Hong Kong 5
RO - Romania 5
AU - Australia 4
CA - Canada 4
IE - Irlanda 4
CY - Cipro 3
DE - Germania 3
ES - Italia 3
GR - Grecia 3
SG - Singapore 3
BA - Bosnia-Erzegovina 2
EG - Egitto 2
ET - Etiopia 2
KW - Kuwait 2
LB - Libano 2
MY - Malesia 2
PL - Polonia 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
BR - Brasile 1
DK - Danimarca 1
DZ - Algeria 1
EC - Ecuador 1
EE - Estonia 1
HR - Croazia 1
IQ - Iraq 1
IR - Iran 1
RS - Serbia 1
SA - Arabia Saudita 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 327
Città #
Milan 32
Fleming Island 27
Abbiategrasso 13
Ashburn 13
Council Bluffs 7
Boardman 4
Dublin 4
New Delhi 4
Tokyo 4
Acton 3
Central 3
Nicosia 3
Revere 3
Austin 2
Banha 2
Birmingham 2
Delhi 2
Guntur 2
Kowloon 2
Kuala Lumpur 2
Kuwait City 2
Melbourne 2
New York 2
Nottingham 2
Port of Spain 2
Sarajevo 2
Tampines New Town 2
Toronto 2
Udine 2
Albuquerque 1
Alcobendas 1
Almada 1
Atlanta 1
Banbridge 1
Barrie 1
Bengaluru 1
Berlin 1
Bishop Auckland 1
Brasov 1
Brooklyn 1
Bucharest 1
Chalandri 1
Champaign 1
Clusone 1
Copenhagen 1
Craiova 1
Dallas 1
Dayton 1
Dubai 1
Egham 1
Estarreja 1
Everett 1
Farrukhabad 1
Fukushima 1
Girona 1
Greenwich 1
Hobart 1
Hoogvliet 1
Iasi 1
Inverness 1
Jukskei Park 1
Kerpen 1
Koganemachi 1
Leyton 1
Liverpool 1
Magalia 1
Marousi 1
Matsudo 1
Mumbai 1
Needham 1
Newcastle upon Tyne 1
Ninove 1
Nuoro 1
Oakland 1
Orlando 1
Osaka 1
Ottawa 1
Oviedo 1
Perth 1
Phoenix 1
Providence 1
Pune 1
Quito 1
Richmond 1
Riyadh 1
Rome 1
Royal Oak 1
Saint Joseph 1
Salt Lake City 1
Sanliurfa 1
Santa Barbara 1
Saronno 1
Settala 1
Shrewsbury 1
Singapore 1
Suceava 1
Tadworth 1
Taguma 1
Tartu 1
Tehran 1
Totale 223
Nome #
Review article: anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease, file de164a8f-2e50-73f5-e053-d805fe0a7be4 37
Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's Disease, file de164a8e-c658-73f5-e053-d805fe0a7be4 29
Comparison between 1.5 and 3.0 Tesla magnetic resonance enterography for the assessment of disease activity and complications in ileo-colonic Crohn's disease, file de164a8f-25cf-73f5-e053-d805fe0a7be4 21
ECCO Position Paper: Harmonization of the Approach to Ulcerative Colitis Histopathology, file de164a8f-1173-73f5-e053-d805fe0a7be4 19
WallFlex colonic stent placement for management of malignant colonic obstruction : a prospective study at two centers, file de164a8f-2f4f-73f5-e053-d805fe0a7be4 11
JAK or GUT Selectivity: Tipping the Balance for Efficacy and Safety in Ulcerative Colitis, file de164a8f-1177-73f5-e053-d805fe0a7be4 10
Bowel damage as assessed by the Lémann Index is reversible on anti-TNF therapy for Crohn's disease, file de164a8f-1ff7-73f5-e053-d805fe0a7be4 9
Short-term outcomes of laparoscopy combined with enhanced recovery pathway after ileocecal resection for Crohn's disease : a case-matched analysis, file de164a8f-2079-73f5-e053-d805fe0a7be4 9
Endoscopic mucosal resection for early colorectal neoplasia: pathologic basis, procedures, and outcomes., file de164a8f-2b66-73f5-e053-d805fe0a7be4 7
VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis, file de164a8f-2c7d-73f5-e053-d805fe0a7be4 7
Infliximab therapy inhibits inflammation-induced angiogenesis in the mucosa of patients with Crohn's disease, file de164a8f-3390-73f5-e053-d805fe0a7be4 7
Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion, file de164a8e-c169-73f5-e053-d805fe0a7be4 6
Direct retrospective comparison of adalimumab and infliximab in preventing early postoperative endoscopic recurrence after ileocaecal resection for Crohn's disease : results from the MULTIPER database, file de164a8e-c051-73f5-e053-d805fe0a7be4 5
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer, file de164a8e-c0e9-73f5-e053-d805fe0a7be4 5
Rho-A prenylation and signaling link epithelial homeostasis to intestinal inflammation, file de164a8e-c45f-73f5-e053-d805fe0a7be4 5
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease : a prospective study, file de164a8f-2643-73f5-e053-d805fe0a7be4 5
Budesonide : teaching an old dog new tricks for inflammatory bowel disease treatment, file de164a8f-29b2-73f5-e053-d805fe0a7be4 5
Step-up and top-down approaches to the treatment of Crohn’s disease: early may already be too late, file de164a8f-32bc-73f5-e053-d805fe0a7be4 5
Prevalence of Bowel Damage Assessed by Cross-Sectional Imaging in Early Crohn's Disease and its Impact on Disease Outcome., file de164a8e-bc49-73f5-e053-d805fe0a7be4 3
Lymphatic endothelium contributes to colorectal cancer growth via the soluble matrisome component GDF11, file de164a8e-c5cc-73f5-e053-d805fe0a7be4 3
Diarrhea During COVID-19 Infection: Pathogenesis, Epidemiology, Prevention, and Management, file de164a8f-0ad2-73f5-e053-d805fe0a7be4 3
Inflammatory Bowel Disease Management During the Coronavirus-19 Outbreak: A Survey From the European Crohn's and Colitis Organization, file de164a8f-1109-73f5-e053-d805fe0a7be4 3
OP018 High-fat diet and inflammation drive intestinal fibrosis enhancing epithelial–mesenchymal transition through the activation of S1P3 signalling, file de164a8f-15fc-73f5-e053-d805fe0a7be4 3
Clinical Trials for Inflammatory Bowel Disease: Global Guidance During the COVID-19 Pandemic, file de164a8f-17a2-73f5-e053-d805fe0a7be4 3
Preoperative magnetic resonance enterography in predicting findings and optimizing surgical approach in Crohn's disease, file de164a8f-25ca-73f5-e053-d805fe0a7be4 3
Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response, file de164a8f-25ce-73f5-e053-d805fe0a7be4 3
The Role of Magnetic Resonance Imaging in Detecting Intestinal Fibrosis in Crohn's Disease, file de164a8f-2600-73f5-e053-d805fe0a7be4 3
Unique role of junctional adhesion molecule-A in maintaining mucosal homeostasis in inflammatory bowel disease, file de164a8e-bcff-73f5-e053-d805fe0a7be4 2
Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis, file de164a8e-c460-73f5-e053-d805fe0a7be4 2
Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study, file de164a8e-c4e2-73f5-e053-d805fe0a7be4 2
The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6, file de164a8e-c6e4-73f5-e053-d805fe0a7be4 2
Letter: thromboembolic and cardiovascular events with tofacitinib in ulcerative colitis-two cases in real world clinical practice. Authors' reply, file de164a8f-0ac9-73f5-e053-d805fe0a7be4 2
Incidence and Patterns of COVID-19 Among Inflammatory Bowel Disease Patients From the Nancy and Milan Cohorts, file de164a8f-1107-73f5-e053-d805fe0a7be4 2
Comparative accuracy of ferritin, transferrin saturation and soluble transferrin receptor for the diagnosis of iron deficiency in inflammatory bowel disease, file de164a8f-116c-73f5-e053-d805fe0a7be4 2
Vedolizumab Efficacy, Safety, and Pharmacokinetics With Reduced Frequency of Dosing From Every 4 Weeks to Every 8 Weeks in Patients With Crohn's Disease or Ulcerative Colitis, file de164a8f-116f-73f5-e053-d805fe0a7be4 2
Histological Remission in Ulcerative Colitis: Under the Microscope Is the Cure, file de164a8f-13c0-73f5-e053-d805fe0a7be4 2
Liver tests abnormalities in COVID-19: trick or treat?, file de164a8f-13c5-73f5-e053-d805fe0a7be4 2
Upadacitinib for Crohn's disease and ulcerative colitis treatment: hitting the selective JAKpot, file de164a8f-156f-73f5-e053-d805fe0a7be4 2
Balancing Risks and Benefits in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic, file de164a8f-173c-73f5-e053-d805fe0a7be4 2
Thiopurines' Metabolites and Drug Toxicity: A Meta-Analysis, file de164a8f-1e02-73f5-e053-d805fe0a7be4 2
mTOR-Dependent Stimulation of IL20RA Orchestrates Immune Cell Trafficking through Lymphatic Endothelium in Patients with Crohn's Disease, file de164a8f-1ff9-73f5-e053-d805fe0a7be4 2
COVID-19 Digestive System Involvement and Clinical Outcomes in a Large Academic Hospital in Milan, Italy, file de164a8f-2375-73f5-e053-d805fe0a7be4 2
Imaging Modalities for Perianal Crohn's Disease, file de164a8f-2790-73f5-e053-d805fe0a7be4 2
Anti-adhesion molecule therapies in inflammatory bowel disease: touch and go, file de164a8f-33c8-73f5-e053-d805fe0a7be4 2
Integrated models of care in managing inflammatory bowel disease: a discussion., file de164a8e-bc61-73f5-e053-d805fe0a7be4 1
Surgical rates in the era of biological therapy: up, down or unchanged?, file de164a8e-bc8f-73f5-e053-d805fe0a7be4 1
New insights into inflammatory bowel disease pathophysiology: Paving the way for novel therapeutic targets, file de164a8e-bceb-73f5-e053-d805fe0a7be4 1
Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease, file de164a8e-bcee-73f5-e053-d805fe0a7be4 1
Inflammation and coagulation in inflammatory bowel disease: The clot thickens, file de164a8e-bcef-73f5-e053-d805fe0a7be4 1
Review article: anti-fibrotic agents for the treatment of Crohn's disease - lessons learnt from other diseases, file de164a8e-bcfa-73f5-e053-d805fe0a7be4 1
Oral Beclomethasone: A Review of its Use in Inflammatory Bowel Disease, file de164a8e-bcfe-73f5-e053-d805fe0a7be4 1
The impact of biologics in surgical outcomes in ulcerative colitis, file de164a8e-bdef-73f5-e053-d805fe0a7be4 1
Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease, file de164a8e-bea4-73f5-e053-d805fe0a7be4 1
Are Surgical Rates Decreasing in the Biological Era In IBD?, file de164a8e-bec5-73f5-e053-d805fe0a7be4 1
Biological agents for ulcerative colitis : Hypes and hopes, file de164a8e-bfaf-73f5-e053-d805fe0a7be4 1
Calcium supplementation for the prevention of colorectal adenomas: a systematic review and meta-analysis of randomized controlled trials, file de164a8e-bfc7-73f5-e053-d805fe0a7be4 1
Patient Perspectives on Biosimilars: A Survey by the European Federation of Crohn's and Ulcerative Colitis Associations, file de164a8e-bfef-73f5-e053-d805fe0a7be4 1
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial, file de164a8e-bff2-73f5-e053-d805fe0a7be4 1
Regulation of leukocyte recruitment by the long pentraxin PTX3., file de164a8e-c01d-73f5-e053-d805fe0a7be4 1
Effect of Adalimumab on Clinical Outcomes and Health-related Quality of Life Among Patients With Ulcerative Colitis in a Clinical Practice Setting: Results From InspirADA, file de164a8e-c091-73f5-e053-d805fe0a7be4 1
Risk factors for complications after ileocolonic resection for Crohn's disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study., file de164a8e-c0dd-73f5-e053-d805fe0a7be4 1
Dose Optimization Is Effective in Patients With Ulcerative Colitis Losing Response to Infliximab: A Collaborative Multicentre Retrospective Study, file de164a8e-c0f3-73f5-e053-d805fe0a7be4 1
Role of bowel ultrasound as a predictor of surgical recurrence of Crohn's disease, file de164a8e-c0f4-73f5-e053-d805fe0a7be4 1
Ulcerative Colitis, file de164a8e-c0f9-73f5-e053-d805fe0a7be4 1
Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study, file de164a8e-c107-73f5-e053-d805fe0a7be4 1
Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients, file de164a8e-c1dc-73f5-e053-d805fe0a7be4 1
Infliximab in Steroid-Dependent Ulcerative Colitis: Efficacy and Predictors of Clinical and Endoscopic Remission, file de164a8e-c335-73f5-e053-d805fe0a7be4 1
Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial, file de164a8e-c424-73f5-e053-d805fe0a7be4 1
Multimodal treatment of perianal fistulas in Crohn's disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial, file de164a8e-c43f-73f5-e053-d805fe0a7be4 1
Full Interchangeability in Regard to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease, file de164a8e-c4de-73f5-e053-d805fe0a7be4 1
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy, file de164a8e-c4e0-73f5-e053-d805fe0a7be4 1
Methylene blue MMX (R) tablets for chromoendoscopy. Safety tolerability and bioavailability in healthy volunteers, file de164a8e-c53c-73f5-e053-d805fe0a7be4 1
Infliximab in Steroid-dependent Ulcerative Colitis: Effectiveness and Predictors of Clinical and Endoscopic Remission, file de164a8e-c5b4-73f5-e053-d805fe0a7be4 1
Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease, file de164a8e-c5bb-73f5-e053-d805fe0a7be4 1
New targeted therapies such as anti-adhesion molecules, anti-IL-12/23 and anti-Janus kinases are looking toward a more effective treatment of inflammatory bowel disease, file de164a8e-c5c0-73f5-e053-d805fe0a7be4 1
Efficacy of Vedolizumab in Fistulising Crohn's Disease: Exploratory Analyses of Data from GEMINI 2, file de164a8e-c659-73f5-e053-d805fe0a7be4 1
Antibodies to infliximab in patients treated with either the reference biologic or the biosimilar CT-P13 show identical reactivity towards biosimilars CT-P13 and SB2 in inflammatory bowel disease, file de164a8e-c743-73f5-e053-d805fe0a7be4 1
Adalimumab in active ulcerative colitis: A "real-life" observational study, file de164a8e-c748-73f5-e053-d805fe0a7be4 1
Surgical conduct in case of intraoperative detection of a Meckel's diverticulum in Crohn's disease, file de164a8e-d959-73f5-e053-d805fe0a7be4 1
Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I), file de164a8e-f270-73f5-e053-d805fe0a7be4 1
Stimulation of CYP450-mediated ω-3 docosahexaenoic acid metabolism via MFSD2A as a novel therapy for inflammatory bowel disease, file de164a8e-ffc6-73f5-e053-d805fe0a7be4 1
Phase I, II and III Trials in Inflammatory Bowel Diseases: A Practical Guide for the Non-specialist, file de164a8f-0ac5-73f5-e053-d805fe0a7be4 1
Views of patients with inflammatory bowel disease on the COVID-19 pandemic: a global survey, file de164a8f-0acd-73f5-e053-d805fe0a7be4 1
Author response to: Covid-19-related pancreatic injury, file de164a8f-1102-73f5-e053-d805fe0a7be4 1
Letter: corticosteroid use alongside tofacitinib in OCTAVE Open. Authors' reply, file de164a8f-116a-73f5-e053-d805fe0a7be4 1
Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease, file de164a8f-11da-73f5-e053-d805fe0a7be4 1
New Drugs in the Ulcerative Colitis Pipeline: Prometheus Unbound, file de164a8f-13bd-73f5-e053-d805fe0a7be4 1
Use of Cross-Sectional Imaging for Tight Monitoring of Inflammatory Bowel Diseases, file de164a8f-13bf-73f5-e053-d805fe0a7be4 1
Inflammatory Bowel Diseases and COVID-19: The Invisible Enemy, file de164a8f-150b-73f5-e053-d805fe0a7be4 1
Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period, file de164a8f-150d-73f5-e053-d805fe0a7be4 1
Maintaining the Quality Standards of Care for Inflammatory Bowel Disease Patients During the COVID-19 Pandemic, file de164a8f-150f-73f5-e053-d805fe0a7be4 1
Inflammatory Bowel Disease Care in the COVID-19 Pandemic Era: The Humanitas, Milan, Experience, file de164a8f-15ce-73f5-e053-d805fe0a7be4 1
SFED recommendations for IBD endoscopy during COVID-19 pandemic: Italian and French experience, file de164a8f-15f4-73f5-e053-d805fe0a7be4 1
Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor, file de164a8f-173d-73f5-e053-d805fe0a7be4 1
Protecting patients with IBD during the COVID-19 pandemic, file de164a8f-179e-73f5-e053-d805fe0a7be4 1
Tofacitinib for Acute Severe Colitis: When the going Gets Tough, the Tough Get Going, file de164a8f-19d3-73f5-e053-d805fe0a7be4 1
More on Covid-19 in Immune-Mediated Inflammatory Diseases, file de164a8f-1cd8-73f5-e053-d805fe0a7be4 1
Point-of-Care Ultrasound in Inflammatory Bowel Disease, file de164a8f-1ef0-73f5-e053-d805fe0a7be4 1
MFSD2A Promotes Endothelial Generation of Inflammation-resolving Lipid Mediators and Reduces Colitis in Mice, file de164a8f-2436-73f5-e053-d805fe0a7be4 1
Totale 320
Categoria #
all - tutte 1140
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1140

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202021 0000 00 00 00021
2020/202125 04115 00 00 2003
2021/202220 1020 10 02 10112
2022/2023261 0012 2023 7368 4215170
Totale 327